Among about 60,000 labeled patients versus more than 200,000 unlabeled patients, the label was linked to 14% higher all-cause mortality.

Among about 60,000 labeled patients versus more than 200,000 unlabeled patients, the label was linked to 14% higher all-cause mortality.

More from this video

See all →

Don't lose this one

A free account saves insights like this to your Boards, and Korva resurfaces them so you actually remember.